Study of cervical cancer treatment patterns in Italy
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at the types of treatments and disease characteristics in people with cervical cancer that is locally advanced (cannot be removed by surgery) or has come back or spread. It may help doctors understand how different treatments are used in Italy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You have been diagnosed with cervical cancer.
- Your cancer is either locally advanced (cannot be treated with surgery to cure it), or it has come back after treatment, or it has spread to other parts of the body.
- You received treatment for advanced cervical cancer between January 2018 and December 2021.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of three types of cancer-fighting drugs—an immunotherapy (camrelizumab), a targeted therapy (famitinib), and chemotherapy—to treat cervical cancer that has returned or spread. The goal is to see if this combination works better than standard treatment.
This trial tests a new immunotherapy drug, serplulimab, for people with locally advanced cervical cancer. The goal is to see if it can help shrink or control the cancer before standard treatments.
This study compares two staging methods—using surgery results versus imaging tests—to help doctors plan treatment for locally advanced cervical cancer. It may improve how accurately the cancer is mapped, which could affect treatment choices and outcomes.
This study collects information from patients diagnosed with endometrial cancer (a cancer of the uterus lining) to understand patterns of the disease and how it behaves. Researchers will review your medical records and cancer tissue samples to learn more about treatment outcomes.
This study is for adults newly diagnosed with lymphoma in the last 3 months, including those who may have started treatment. It aims to collect information on patients in Italy.
This study looks at how different treatments (surgery, radiation, or medication) affect survival, complications, and quality of life in people with head and neck cancer. It aims to understand which treatments work best and why.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.